Amy Smith
Registered Nurse · Bel Air, MDNPI 1952986127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,941 and has fallen 61.7% since, to $743 in 2025. Among registered nurse clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$734
- Collegium Pharmaceutical, Inc.$653
- Scilex Pharmaceuticals Inc.$578
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$499
- Protega Pharmaceutials Inc$292
- Electronic Waveform Lab, Inc.$116
- plus $862 from 19 others
What the payments were for
- Food & beverage$3,735100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $734 |
| Collegium Pharmaceutical, Inc. | 38 | $653 |
| Scilex Pharmaceuticals Inc. | 30 | $578 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $499 |
| Protega Pharmaceutials Inc | 16 | $292 |
| Electronic Waveform Lab, Inc. | 9 | $116 |
| Vertos Medical, Inc. | 5 | $99 |
| Averitas Pharma Inc. | 4 | $96 |
| GSK | 4 | $84 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
| Biotronik NRO, Inc. | 3 | $67 |
| Vertex | 4 | $67 |
| Boston Scientific | 3 | $53 |
| Curonix LLC | 2 | $41 |
| Saluda Medical Americas, Inc. | 2 | $39 |
| Tersera Therapeutics LLC | 2 | $39 |
| MML US, Inc. | 1 | $30 |
| International Rehabilitative Sciences, Inc | 2 | $30 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $29 |
| Almatica Pharma LLC | 1 | $27 |
| Amgen | 1 | $22 |
| GRT US Holding, Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $20 |
| Medtronic | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $14 |
How this compares
$3,735 in reported general payments places this provider in the 95th percentile of 89 registered nurse providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 91 | $38,243 |
| Oxycodone Hcl | 1,689 | $36,855 |
| BelbucaBuprenorphine Hcl | 36 | $33,007 |
| Xtampza ErOxycodone Myristate | 78 | $32,970 |
| LyricaPregabalin | 16 | $24,204 |
| RoxybondOxycodone Hcl | 13 | $20,255 |
| NucyntaTapentadol Hcl | 20 | $14,622 |
| Nucynta ErTapentadol Hcl | 13 | $13,962 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 528 | $13,672 |
| Lidocaine | 134 | $9,063 |
| ZtlidoLidocaine | 18 | $8,992 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 327 | $8,285 |
| Morphine Sulfate ErMorphine Sulfate | 246 | $5,060 |
| Gabapentin | 315 | $4,075 |
| Fentanyl | 39 | $3,435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta, Nucynta Er | $653 | $94,561147 claims |
| Protega Pharmaceutials IncRoxybond | $292 | $20,25513 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $578 | $8,99218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 89 registered nurse providers in Maryland.
Other registered nurse in Bel Air
- Michele BrownBel Air$1K
- Tomeeka HawthorneColumbia$9K
- Denise WilsonLavale$6K
- Kathryn WattsAnnapolis$5K
- Jennifer HubbardRandallstown$4K
- Lindsay BlairBaltimore$2K
- Rachael FornwaltColumbia$1K
- Lou BartoloChevy Chase$695
- Margaret CloughBaltimore$635
- Haley ZimmermanPasadena$614
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.